Inferra AI / Company / NSP

Insperity, Inc..

NSP · Industrials

Last earnings Oct 29, 2026

Key results

Revenuequarter

4%

revenues up 4% year-over-year Q3 average paid

SEC original ↗Insperity, Inc.. — Earnings release (8-K exhibit)EX-99Nov 3, 2025

YTD net incomeytd

$26 million

YTD net income of $26 million adjusted EBITDA of $144 million

SEC original ↗Insperity, Inc.. — Earnings release (8-K exhibit)EX-99Nov 3, 2025

YTD net incomeQ3 2025

$144 million

YTD net income of $26 million adjusted EBITDA of $144 million

SEC original ↗Insperity, Inc.. — Earnings release (8-K exhibit)EX-99Nov 3, 2025

YTD EPSytd

$0.69

YTD diluted EPS of $0.69 adjusted EPS of $1.63 Return to shareholders of $87 million during the first nine months of 2025 through the repurchase of 225,000 shares at a cost of $19 million and $68 million in cash dividends UHC contract extended through 2028 providing significant cost savings, lower risk

SEC original ↗Insperity, Inc.. — Earnings release (8-K exhibit)EX-99Nov 3, 2025

Revenues in Q3 2025 increased 4% to $1.6 billion on a 3% increase in revenue per WSEE on higher pricing and the increase in paid WSEEs.

SEC original ↗Insperity, Inc.. — Earnings release (8-K exhibit)EX-99Nov 3, 2025

Revenues increased by 4% to $5.1 billion on a 3% increase in revenue per WSEE and the increase in paid WSEEs.

SEC original ↗Insperity, Inc.. — Earnings release (8-K exhibit)EX-99Nov 3, 2025

EPSquarter

$26 million

Reported net income and diluted EPS were $26 million and $0.69, respectively.

SEC original ↗Insperity, Inc.. — Earnings release (8-K exhibit)EX-99Nov 3, 2025

With 2024 revenues of $6.6 billion and more than 90 sales offices throughout the U.

SEC original ↗Insperity, Inc.. — Earnings release (8-K exhibit)EX-99Nov 3, 2025

AI analysis

Q3 2025 · reported Nov 3, 2025

Based on: Earnings release + parent 8-K — transcript not held

YTD net income · Q3 2025
$144M
EX-99 · Nov 3, 2025
EPS · Q3 2025
$26M
EX-99 · Nov 3, 2025

Headline figures

MetricQ3 2025Prior qtrYear ago
Revenue4%——
YTD net income$144 million——
EPS$26 million——

EX-99 · Nov 3, 2025

Guidance · company-stated

No guidance located in the held release

Stated figure28%
Next earningsNo verified date on fileNo date is estimated or imported

Capital allocation

Dividend$68M
Capex$22M

Cash outlays in the first nine months of 2025 included the repurchase of approximately 225,000 shares of our common stock at a cost of $19 million, dividends totaling $68 million, and capital expenditures of $22 million.

Company-stated claims

Oct 29, 2026

Historical · increased 210% · ebitda

“Adjusted EBITDA increased 210% to $31 million and adjusted EPS increased 210% to $0.22.”

EX-99 · Oct 29, 2026
General educational research only — not investment advice.Every figure is as stated in the held documents; values marked “computed from stated figures” are arithmetic on those stated figures. Guidance shown is the company’s own stated guidance. No price targets, no recommendations, no consensus estimates.

Event summary

Insperity Announces Third Quarter Results and New UnitedHealthcare Contract

Based on: Earnings release + parent 8-K — transcript not held

Guidance & outlook

No guidance located in the held release

Capital allocation

Cash outlays in the first nine months of 2025 included the repurchase of approximately 225,000 shares of our common stock at a cost of $19 million, dividends totaling $68 million, and capital expenditures of $22 million.

SEC original ↗Insperity, Inc.. — Earnings release (8-K exhibit)EX-99Nov 3, 2025

Adjusted cash at September 30, 2025 totaled $120 million and we had outstanding borrowings of $370 million under our $650 million credit facility.

SEC original ↗Insperity, Inc.. — Earnings release (8-K exhibit)EX-99Nov 3, 2025

Strategy & priorities

We are simultaneously taking assertive actions, including through the new contract with UnitedHealthcare, and will continue to focus on attracting and retaining the right clients at the right price and prudently managing expenses, said Paul J.

SEC original ↗Insperity, Inc.. — Earnings release (8-K exhibit)EX-99Nov 3, 2025

We are also pleased to announce the official rollout of HRScale, our strategic joint development offering with Workday.

SEC original ↗Insperity, Inc.. — Earnings release (8-K exhibit)EX-99Nov 3, 2025

We believe the structure of the agreement improves our financial outlook substantially for 2026 and enhances strategic alignment for growth and profitability in subsequent years.

SEC original ↗Insperity, Inc.. — Earnings release (8-K exhibit)EX-99Nov 3, 2025

Operating expenses included $11 million and $19 million for our Workday strategic partnership in Q3 2025 and Q3 2024, respectively.

SEC original ↗Insperity, Inc.. — Earnings release (8-K exhibit)EX-99Nov 3, 2025

Operating expenses included $38 million for our Workday strategic partnership in YTD 2025.

SEC original ↗Insperity, Inc.. — Earnings release (8-K exhibit)EX-99Nov 3, 2025

Risks & headwinds

Forward-looking statements involve a number of risks and uncertainties.

SEC original ↗Insperity, Inc.. — Earnings release (8-K exhibit)EX-99Nov 3, 2025

We caution you that these statements are not guarantees of future performance and involve risks, uncertainties and assumptions that we cannot predict.

SEC original ↗Insperity, Inc.. — Earnings release (8-K exhibit)EX-99Nov 3, 2025

Documents

Earnings deck slides

2 decks with slide view

Competitors

Competitors & peers

Same GICS sector — classification peers, not declared competitors

Filings

32 documents

Earnings releases

11 documents

Presentations

2 documents

Transcripts

0 documents

No transcripts for Insperity, Inc.. are held in this edition of the library.

Mentioned by

2 companies

Other tracked companies whose held documents mention Insperity, Inc.. by name or ticker. A mention is counted once per document, from the document text the library holds.

See also the earnings calendar for every tracked company’s next earnings date.